Dr. Stephen Hahn, a radiation oncologist, has stepped down from his position as FDA commissioner and will be replaced in the interim by Dr. Janet Woodcock, director of the agency's Center for Drug Evaluation and Research. Hahn was part of the American Society for Radiation Oncology's board of directors before former President Donald Trump nominated him for the position in November 2019, a move celebrated by the radiation oncology community.
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.